Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Melinda Epstein"'
Autor:
Lisa E. Guerra, Melvin J. Silverstein, Peter Chen, Melinda Epstein, Brian S. Kim, Lincoln Snyder, Colleen Coleman, Kevin Lin, Sadia Khan
Publikováno v:
Annals of Surgical Oncology. 25:2987-2993
Two prospective, randomized trials, TARGIT-A and ELIOT, have shown intraoperative radiation therapy to be a safe alternative, with a low-risk of local recurrence, compared with whole breast radiation therapy, following breast-conserving surgery, for
Autor:
January Lopez, Sadia Khan, Ralph Mackintosh, Colleen Coleman, Lincoln Snyder, Lisa E. Guerra, Melvin J. Silverstein, Melinda Epstein, Cristina de Leon, Peter Chen, Brian S. Kim, Kevin Lin
Publikováno v:
The Breast Journal. 22:630-636
Intraoperative radiation therapy (IORT) delivers radiation therapy directly to the tumor bed at the time of surgery. Minimal data are available regarding IORT complications in patients diagnosed with ductal carcinoma in situ (DCIS) using the Xoft® A
Autor:
Peter Chen, Colleen Coleman, Cristina de Leon, Ralph Mackintosh, Lisa Guerra, Lincoln Snyder, Melvin J. Silverstein, Melinda Epstein, Kevin Lin, Sadia Khan, January Lopez, Brian S. Kim
Publikováno v:
Annals of Surgical Oncology. 23:3304-3309
Intraoperative radiation therapy (IORT) permits the delivery of radiation therapy directly to the tumor bed at the time of surgery. Minimal data are available about the complications associated with this modality of treatment using the Xoft(®) Axxen
Autor:
Cristina de Leon, Lincoln Snyder, Lisa E. Guerra, Peter Chen, Ralph Mackintosh, Brian S. Kim, Melvin J. Silverstein, Melinda Epstein, Sadia Khan, Colleen Coleman, January Lopez, Kevin Lin
Publikováno v:
Annals of surgical oncology. 24(10)
Two prospective, randomized trials, TARGIT-A and ELIOT, have shown intraoperative radiation therapy (IORT) to be a safe alternative to whole breast radiation therapy following breast-conserving surgery for selected low-risk patients. However, minimal
Publikováno v:
Annals of surgical oncology. 24(1)
During 2015, the media was flooded with the issue of whether ductal carcinoma in situ (DCIS) was being overtreated and whether favorable cases could be simply watched (core biopsy only followed by surveillance). To answer this question, we looked at
Autor:
Melvin J. Silverstein, Melinda Epstein, Jessica Ryan, Cristina DeLeon, Sadia Khan, Nirav B. Savalia, Brian S. Kim, Peter Chen
Publikováno v:
Annals of Surgical Oncology
A standard Wise-pattern reduction can be used to excise a breast cancer that falls within the Wise pattern.1 When the tumor is located outside the Wise pattern, it can be removed by tunneling and pulling the lesion through the Wise-pattern incision.
Autor:
Dennis J. Slamon, Melinda Epstein, Jean-Michel Vernes, He-Jing Wang, Y. Gloria Meng, Mark D. Pegram, Hermann Hepp, Kyu Hong, Michael Untch, Johnny Gutierrez, Petra Stieber, Gottfried E. Konecny, Ingo Bauerfeind, Malgorzata Beryt
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(5)
Purpose: Activation or overexpression of HER-2/neu is associated with up-regulation of vascular endothelial growth factor (VEGF) in human breast cancer cells in vitro. Preclinical experiments indicate that increased expression of VEGF may in part med
Publikováno v:
Advances in Anatomic Pathology. 13:200-201
Autor:
Melinda Epstein, Stephanie H. Astrow, Afsaneh Barzi, Takeru Wakatsuki, Heinz-Josef Lenz, Martin K. H. Maus, Diana L. Hanna, Jack Hsiang, Dongyun Yang, Fotios Loupakis, Gary Zeger, Peter P. Grimminger, Craig Stephens
Publikováno v:
Journal of Clinical Oncology. 31:3527-3527
3527 Background: Recent data suggests that CRC from different locations show distinct genetic profiles. Right-sided tumors have a worse prognosis and may have less benefit from targeted therapies. We investigated the tumor locations and genetic profi
Publikováno v:
Advances in Anatomic Pathology; Jul2006, Vol. 13 Issue 4, p200-201, 2p